Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cardiff, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Viracta Therapeutics, Inc. has filed 1,181 SEC EDGAR filings since 07 Aug 2002

SEC filing history

Showing 726-750 of 861 matching filings.

Per page
25
Current page
30
CT ORDER File 000-51531

CT ORDER filing

Filing date
18 Jun 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
11 Jun 2012
Reporting date
05 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
15 May 2012
Reporting date
15 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-51531

AUTO-GENERATED PAPER DOCUMENT

Filing date
25 Apr 2012
Reporting date
31 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-51531

DEFINITIVE ADDITIONAL MATERIALS

Filing date
23 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-51531

DEFINITIVE PROXY STATEMENT

Filing date
23 Apr 2012
Reporting date
05 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
03 Apr 2012
Reporting date
29 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
28 Mar 2012
Reporting date
22 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-180101

FORM S-8

Filing date
14 Mar 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
14 Mar 2012
Reporting date
14 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
02 Mar 2012
Reporting date
29 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
02 Mar 2012
Reporting date
27 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
02 Mar 2012
Reporting date
29 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
02 Mar 2012
Reporting date
29 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
24 Feb 2012
Reporting date
20 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SCHEDULE 13G

Filing date
13 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

AMENDMENT NO. 4

Filing date
08 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
03 Feb 2012
Reporting date
31 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
30 Nov 2011
Reporting date
28 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Nov 2011
Reporting date
21 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
14 Nov 2011
Reporting date
14 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
19 Oct 2011
Reporting date
18 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .